PhonePe Invest
Brooks Laboratories Ltd.

Brooks Laboratories Ltd.

BROOKS

Small CapPharmaceuticals
Brooks Laboratories Ltd.

Brooks Laboratories Ltd.

BROOKS

Small CapPharmaceuticals

Brooks Laboratories Ltd. Share Price

67.57 -2.85 (-4.05%)

Share Price Today – Brooks Laboratories Ltd.

As of October 16, 2026, Brooks Laboratories Ltd. share price is ₹67.57. The stock opened at ₹70.06 and closed at ₹70.42 in the previous session. During the trading session, the share price moved between ₹66.55 and ₹72.50. Over the last 52 weeks, the stock has recorded a low of ₹36.30 and a high of ₹129.44. In terms of performance, the stock has delivered -2.9% returns over the past six months and -43.2% returns over the last year.

About the company

Brooks Laboratories is engaged in pharmaceutical activities
Crisp AnalysisAnalysis

Solid quality with volatility risks

Today's Low
66.55
Today's High
72.50
52W Low
36.30
52W High
129.44

Fundamentals

Market Cap

₹206Cr

EPS

₹8.35

Book Value/Share

₹42.12

P/E Ratio (TTM)

15.70

Industry P/E (TTM)

45.10

P/B Ratio

1.69

Long Term D/E

0.06

ROE

22.27%

Dividend Yield (TTM)

0.00%

Sector P/E Ratio (TTM)

39.51

Sector P/B Ratio

5.33

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

Top mutual funds holding Brooks Laboratories Ltd.

FAQs on Brooks Laboratories Ltd.

The share price of Brooks Laboratories Ltd. is ₹67.57 on NSE as of 16/10/2026, 10:08:38 pm. Share prices may change frequently due to market movements.

The market capitalisation of Brooks Laboratories Ltd. is ₹206Cr as of 16/10/2026, 10:08:38 pm

The current Price to Earnings (P/E) ratio of Brooks Laboratories Ltd. is 15.70 as of 16/10/2026, 10:08:38 pm

The Price to Book (P/B) ratio of Brooks Laboratories Ltd. stands at 1.69 as of 16/10/2026, 10:08:38 pm

Brooks Laboratories Ltd. reported an ROE of 22.27% for the last reported financial year on a consolidated account basis.

As of 16/10/2026, 10:08:38 pm, Brooks Laboratories Ltd.’s shareholding pattern is: promoters hold 52.60%, FIIs hold 0.00%, DIIs hold 0.50%, and public shareholders hold 37.00%.

The 52-week high of Brooks Laboratories Ltd. is ₹129.44 and the 52-week low is ₹36.30 as of 16/10/2026, 10:08:38 pm.

The earnings per share (EPS) of Brooks Laboratories Ltd. is -- for the quarter ended Sep 2026.

The stock symbol of Brooks Laboratories Ltd. is BROOKS.

You can buy Brooks Laboratories Ltd. shares by opening a demat and trading account with PhonePe Invest and placing a buy order on NSE or BSE during market hours.

The fair value of Brooks Laboratories Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Market like performer

Good Quality

High Price Fluctuation

Disclosure and Disclaimer

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue22.96+13.61%
Other Income0.18-59.09%
Total Income23.14+12.06%
Total Expenditure21.10+8.04%
EBIDT2.04+82.14%
Depreciation0.42+2.44%
Interest0.21+133.33%
Tax0.00-
Net Profit-1.79-217.76%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets37.42
Total Non-Current Assets110.76
Fixed assets15.71
Total Assets148.17
Total Current liabilities21.81
Total Non Current Liabilities3.70
Total Equity Plus Liabilities148.17
Total Shareholder Funds122.66
Total Debt to Equity6.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity9.29
Cash from Financing Activities0.17
Cash from Investing Activities-2.92
Net Cash Flow6.54

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages15

Bearish Moving Averages1

5 Day

67.90

10 Day

63.60

20 Day

61.30

30 Day

62.30

50 Day

62.20

100 Day

64.80

150 Day

62.20

200 Day

64.20

Indicators

RSI (14)

62.96

MACD (12, 26)

1.57

MACD Signal Line (9)

0.17

MFI (14)

85.38

ATR (14)

4.91

ADX (14)

20.10

ROC (21)

11.62

ROC (125)

1.21

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic0.000.000.000.000.000.000.00

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Market like performer

Good Quality

High Price Fluctuation

Disclosure and Disclaimer
Brooks Laboratories Ltd.

Brooks Laboratories Ltd.

BROOKS

Small CapPharmaceuticals

Open Price

70.06

Previous Close

70.42

Volume

1,22,176

Average Price

69.03

Upper Circuit

84.50

Lower Circuit

56.34
Today's Low
66.55
Today's High
72.50
52W Low
36.30
52W High
129.44

Historical Performance

Momentum 3/5
NA1 Day
NA5 Days
NA1 Month
NA3 Months
NA1 Year
NA5 Years
NA10 Years
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.